Breaking News, Collaborations & Alliances

BioDuro, Atombeat Launch AI-Powered Platform for Accelerated Peptide Drug Discovery

This platform aims to deliver high-quality cyclic peptides with faster timelines and better economy across a broad range of therapeutic areas.

By: Rachel Klemovitch

Assistant Editor

BioDuro, a global CRDMO, and Atombeat Inc., a leading force in AI for drug discovery, entered a strategic collaboration to develop an AI-powered platform to accelerate peptide drug discovery. This collaboration combines Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform, with BioDuro’s expertise in discovery chemistry, biology, and DMPK to accelerate the development of next-generation peptides.  Atombeat accelerates AI-driven drug discovery throu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters